(Q43639859)

English

Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease

scientific article published on 16 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

object named as

Lucie Blais

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Marie-France Beauchesne

2

object named as

Marie-France Beauchesne

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Catherine Lemière

3

object named as

Catherine Lemière

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Marie-Christyne Cyr

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

16 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

613-622

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Inhaled corticosteroids moderate lung function decline in adults with asthma

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Pharmacoepidemiology II: the nested case-control study--a novel approach in pharmacoepidemiologic research

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Biased Selection of Controls for Case-Control Analyses of Cohort Studies

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

A chronic disease score from automated pharmacy data

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Immortal time bias in observational studies of drug effects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Contemporary management of chronic obstructive pulmonary disease: scientific review

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M243

21 January 2018

Identifiers

10.1345/APH.1M243

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43639859&oldid=2102042714"